Universitätsklinikum Tübingen

DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast (2014) Souchon R, Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, et al. Journal article Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer (2014) Kamat AM, Vlahou A, Taylor JA, Hudson MA, Pesch B, Ingersoll MA, Todenhöfer T, et al. Journal article How nescience may obscure evidence (2014) Sautter-Bihl ML, Sedlmayer F, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article DEGRO practical guidelines for radiotherapy of breast cancer IV: radiotherapy following mastectomy for invasive breast cancer (2014) Wenz F, Sperk E, Budach W, Dunst J, Feyer P, Fietkau R, Haase W, et al. Journal article A Wizard-Based Segmentation Approach for Cochlear Implant Planning (2014) Franz D, Hofer M, Pfeifle M, Pirlich M, Stamminger M, Wittenberg T Conference contribution, Conference Contribution Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV (2014) Kalmanti L, Saussele S, Lauseker M, Proetel U, Mueller MC, Hanfstein B, Schreiber A, et al. Journal article End-stage renal disease after sarcoma therapy - case 3/2014 (2014) Baumann D, Amann KU, Schlatter E, Ciarimboli G, Kopp HG, Müller M, Kluba T, et al. Journal article Effectiveness and tolerability of ipilimumab: experiences from 198 patients included in a named-patient program in various daily-practice settings and multiple institutions (2014) Eigentler TK, Schlaak M, Hassel JC, Loquai C, Stoffels I, Gutzmer R, Paetzold S, et al. Journal article Anterosuperior diverticula of the right ventricle: morphological spectrum and long-term outcome of a distinct cardiac anomaly (2014) Wiegand G, Rauch R, Singer H, Koch A, Hofbeck M Journal article Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV (2014) Hehlmann R, Müller MC, Lauseker M, Hanfstein B, Fabarius A, Schreiber A, Proetel U, et al. Journal article